Results 71 to 80 of about 1,253,166 (338)

Fluoxetine Can Inhibit SARS-CoV-2 In Vitro

open access: yesMicroorganisms, 2021
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in the coronavirus disease pandemic, drastically affecting global health and economy.
Arthur Dechaumes   +7 more
doaj   +1 more source

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

open access: yesBritish medical journal, 2020
Objective To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. Design Retrospective case series. Setting Tongji Hospital in Wuhan, China.
Tao Chen   +20 more
semanticscholar   +1 more source

Regulatory effect of gut microbes on blood pressure

open access: yesAnimal Models and Experimental Medicine, Volume 5, Issue 6, Page 513-531, December 2022., 2022
The interaction between gut microbiota and hypertension, the genera which affect the blood pressure in taxonomic level, and the commonly used treatments to hypertension based on the gut microbes were summarized in this review. The increases of Lactobacillus, etc.
Dong Yan   +6 more
wiley   +1 more source

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

open access: yeseLife, 2021
Combating the COVID-19 pandemic requires potent and low-cost therapeutics. We identified a series of single-domain antibodies (i.e., nanobody), Nanosota-1, from a camelid nanobody phage display library. Structural data showed that Nanosota-1 bound to the
Gang Ye   +14 more
doaj   +1 more source

Coronavirus Update 2-3-22 [PDF]

open access: yes, 2022
There will be two booster clinics on campus this weekend that will be open to students, faculty and staff and their family ...
The Coronavirus Planning Team,
core   +1 more source

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

open access: yesJAMA cardiology, 2020
This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
T. Guo   +9 more
semanticscholar   +1 more source

Coronavirus Update 10-2-20 [PDF]

open access: yes, 2020
Our ramped-up random testing of asymptomatic students went well this week, and we are processing the results. We tested more than 1,200 students and some faculty and staff. Next week, we begin saliva testing and will test even more community members. The
The Coronavirus Planning Team,
core   +5 more sources

Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China

open access: yesFrontiers in Public Health, 2022
COVID-19, referred to as new coronary pneumonia, is an acute infectious disease caused by a new type of coronavirus SARS-CoV-2. To evaluate the effect of integrated Chinese medicine and Western medicine in patients with COVID-19 from overseas.
Yu-Xuan Huang   +15 more
doaj   +1 more source

Coronavirus Update 1-8-21 [PDF]

open access: yes, 2021
It has been a long haul since March, but we now know how critical it is not to socialize in groups—big or small—especially without masks and social distancing.
The Coronavirus Planning Team,
core   +3 more sources

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

open access: yesJournal of Virology, 2020
The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002 to 2003. Our decade-long structural studies on the receptor recognition by SARS-CoV have identified key interactions ...
Yushun Wan   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy